You can’t go far lately without seeing news and social media coverage of GLP-1 (glucagon-like peptide-1) receptor agonists like Ozempic®, Wegovy®, Mounjaro®, and Zepbound®. While Ozempic can be great ...

Add Yahoo as a preferred source to see more of our stories on Google. Semaglutide helps with weight loss, but may cause muscle loss in women and older adults. Protein intake could help reduce this ...

Social media influencers and supplement companies have stoked concerns, but experts say the issue is a lot more complicated.

"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." In a perfect world, you’d lose fat while keeping your muscle mass intact. Unfortunately, it’s common for ...

Women's Health may earn commission from the links on this page, but we only feature products we believe in. Why Trust Us? There are two drugs, currently in clinical trials, aiming to help patients ...

TORONTO — GLP-1 receptor agonists (RAs) have transformed diabetes and obesity management, offering improvements in glycemic control and weight loss and reductions in cardiometabolic risk. But “an ...

GLP-1 agonist medications (Ozempic and Wegovy) and dual GIP/GLP-1 receptor agonist medications (Zepbound and Mounjoaro) are powerful tools for weight loss, but losing weight rapidly can also lead the ...